Clinical Trial Update: The Vascular Effects of Vildagliptin in Insulin Resistant Individuals [Phase 3]

View source ↗

Summary

Phase 3 study evaluating vascular effects of vildagliptin in insulin-resistant individuals with microvascular concerns; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Microvascular Disease

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Insulin Resistance, Microvascular Disease | Phase 3 | Status: COMPLETED